Subscribe

Biocompounding

Biocompounding

A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH

A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH

1) Eli Lilly (NYSE: LLY) enters into collaboration with Nimbus to develop therapeutics for metabolic diseases Eli Lilly and Nimbus enter into a collaboration to develop therapeutics for metabolic diseases. The two companies will collaborate on the development of novel targeted therapies designed to activate a specific isoform of AMPK

3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery

3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery

1) Bristol Myers Squibb (BMS) enters into 2 licensing deals with SynethX and Autolus Therapeutics (AUTL) Bristol Myers Squibb (NYSE: BMS) entered into 2 licensing deals with SynethX Inc and Autolus Therapeutics (NASDAQ: AUTL). The first deal is with SynethX which will focus on discovering molecular glue degraders. Synethx has

A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)

A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)

3 Top Biotech News Of The Week (1 October 22)

3 Top Biotech News Of The Week (1 October 22)

1) Eisai and Biogen Report Positive Phase III Data for Anti-Amyloid Alzheimer's Drug Eisai and Biogen announced that the duo’s Alzheimer's drug, Lecanemab, slowed the rate of cognitive decline for early Alzheimer’s participants in the phase 3 clinical trial by 27% compared to a

An Overview of RNA Technologies

An Overview of RNA Technologies

RNA technologies made headlines in 2021 when the first mRNA-based COVID-19 vaccine was approved in December 2020. However, RNA therapy is not a new technology. RNA modalities have been under development for several decades and by Jan 2020, the U.S Food and Drug Administration (FDA) had approved a total

3 Top Biotech News Of The Week (17 September 22) - Bioeconomy executive order, BioMarin, Danaher, Intellia

3 Top Biotech News Of The Week (17 September 22) - Bioeconomy executive order, BioMarin, Danaher, Intellia

1. The US Govt just released the Executive Order for advancing biotechnology and biomanufacturing for a sustainable, safe, and secure bioeconomy. There are 11 areas they will be looking to fund and develop within this niche. Here is a quick summary: 1. Coordinate investment in key R&D areas

3 Top Biotech News Of The Week (10 September 22)

3 Top Biotech News Of The Week (10 September 22)

1. Iveric plans FDA submission of data for geographic atrophy eye-drug following study success Iveric Bio announced positive phase 3 topline data from Zimura for geographical atrophy (GA). Zimura is a novel investigational complement C5 inhibitor. Overactivity of the complement system and the C5 protein are suspected to play a